Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
NSAIDs Drug market report explains the definition, types, applications, major countries, and major players of the NSAIDs Drug market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Allergan
Purdue
J&J
Sanofi
Merck
Yunnan Baiyao
Eli Lilly
Depomed
Bayer
AstraZeneca
Grunenthal
GSK
Teva
Pfizer
Endo
By Type:
Generic
Branded
By End-User:
Hospitals
Clinics
Drugstores
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global NSAIDs Drug Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 NSAIDs Drug Outlook to 2028- Original Forecasts
-
2.2 NSAIDs Drug Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term NSAIDs Drug Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global NSAIDs Drug Market- Recent Developments
-
6.1 NSAIDs Drug Market News and Developments
-
6.2 NSAIDs Drug Market Deals Landscape
7 NSAIDs Drug Raw Materials and Cost Structure Analysis
-
7.1 NSAIDs Drug Key Raw Materials
-
7.2 NSAIDs Drug Price Trend of Key Raw Materials
-
7.3 NSAIDs Drug Key Suppliers of Raw Materials
-
7.4 NSAIDs Drug Market Concentration Rate of Raw Materials
-
7.5 NSAIDs Drug Cost Structure Analysis
-
7.5.1 NSAIDs Drug Raw Materials Analysis
-
7.5.2 NSAIDs Drug Labor Cost Analysis
-
7.5.3 NSAIDs Drug Manufacturing Expenses Analysis
8 Global NSAIDs Drug Import and Export Analysis (Top 10 Countries)
-
8.1 Global NSAIDs Drug Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global NSAIDs Drug Export by Region (Top 10 Countries) (2017-2028)
9 Global NSAIDs Drug Market Outlook by Types and Applications to 2022
-
9.1 Global NSAIDs Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Generic Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Branded Consumption and Growth Rate (2017-2022)
-
9.2 Global NSAIDs Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Drugstores Consumption and Growth Rate (2017-2022)
10 Region and Country-wise NSAIDs Drug Market Analysis and Outlook till 2022
-
10.1 Global NSAIDs Drug Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States NSAIDs Drug Consumption (2017-2022)
-
10.2.2 Canada NSAIDs Drug Consumption (2017-2022)
-
10.2.3 Mexico NSAIDs Drug Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany NSAIDs Drug Consumption (2017-2022)
-
10.3.2 UK NSAIDs Drug Consumption (2017-2022)
-
10.3.3 Spain NSAIDs Drug Consumption (2017-2022)
-
10.3.4 Belgium NSAIDs Drug Consumption (2017-2022)
-
10.3.5 France NSAIDs Drug Consumption (2017-2022)
-
10.3.6 Italy NSAIDs Drug Consumption (2017-2022)
-
10.3.7 Denmark NSAIDs Drug Consumption (2017-2022)
-
10.3.8 Finland NSAIDs Drug Consumption (2017-2022)
-
10.3.9 Norway NSAIDs Drug Consumption (2017-2022)
-
10.3.10 Sweden NSAIDs Drug Consumption (2017-2022)
-
10.3.11 Poland NSAIDs Drug Consumption (2017-2022)
-
10.3.12 Russia NSAIDs Drug Consumption (2017-2022)
-
10.3.13 Turkey NSAIDs Drug Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China NSAIDs Drug Consumption (2017-2022)
-
10.4.2 Japan NSAIDs Drug Consumption (2017-2022)
-
10.4.3 India NSAIDs Drug Consumption (2017-2022)
-
10.4.4 South Korea NSAIDs Drug Consumption (2017-2022)
-
10.4.5 Pakistan NSAIDs Drug Consumption (2017-2022)
-
10.4.6 Bangladesh NSAIDs Drug Consumption (2017-2022)
-
10.4.7 Indonesia NSAIDs Drug Consumption (2017-2022)
-
10.4.8 Thailand NSAIDs Drug Consumption (2017-2022)
-
10.4.9 Singapore NSAIDs Drug Consumption (2017-2022)
-
10.4.10 Malaysia NSAIDs Drug Consumption (2017-2022)
-
10.4.11 Philippines NSAIDs Drug Consumption (2017-2022)
-
10.4.12 Vietnam NSAIDs Drug Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil NSAIDs Drug Consumption (2017-2022)
-
10.5.2 Colombia NSAIDs Drug Consumption (2017-2022)
-
10.5.3 Chile NSAIDs Drug Consumption (2017-2022)
-
10.5.4 Argentina NSAIDs Drug Consumption (2017-2022)
-
10.5.5 Venezuela NSAIDs Drug Consumption (2017-2022)
-
10.5.6 Peru NSAIDs Drug Consumption (2017-2022)
-
10.5.7 Puerto Rico NSAIDs Drug Consumption (2017-2022)
-
10.5.8 Ecuador NSAIDs Drug Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain NSAIDs Drug Consumption (2017-2022)
-
10.6.2 Kuwait NSAIDs Drug Consumption (2017-2022)
-
10.6.3 Oman NSAIDs Drug Consumption (2017-2022)
-
10.6.4 Qatar NSAIDs Drug Consumption (2017-2022)
-
10.6.5 Saudi Arabia NSAIDs Drug Consumption (2017-2022)
-
10.6.6 United Arab Emirates NSAIDs Drug Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria NSAIDs Drug Consumption (2017-2022)
-
10.7.2 South Africa NSAIDs Drug Consumption (2017-2022)
-
10.7.3 Egypt NSAIDs Drug Consumption (2017-2022)
-
10.7.4 Algeria NSAIDs Drug Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia NSAIDs Drug Consumption (2017-2022)
-
10.8.2 New Zealand NSAIDs Drug Consumption (2017-2022)
11 Global NSAIDs Drug Competitive Analysis
-
11.1 Allergan
-
11.1.1 Allergan Company Details
-
11.1.2 Allergan NSAIDs Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Allergan NSAIDs Drug Main Business and Markets Served
-
11.1.4 Allergan NSAIDs Drug Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Purdue
-
11.2.1 Purdue Company Details
-
11.2.2 Purdue NSAIDs Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Purdue NSAIDs Drug Main Business and Markets Served
-
11.2.4 Purdue NSAIDs Drug Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 J&J
-
11.3.1 J&J Company Details
-
11.3.2 J&J NSAIDs Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 J&J NSAIDs Drug Main Business and Markets Served
-
11.3.4 J&J NSAIDs Drug Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Sanofi
-
11.4.1 Sanofi Company Details
-
11.4.2 Sanofi NSAIDs Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Sanofi NSAIDs Drug Main Business and Markets Served
-
11.4.4 Sanofi NSAIDs Drug Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Merck
-
11.5.1 Merck Company Details
-
11.5.2 Merck NSAIDs Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Merck NSAIDs Drug Main Business and Markets Served
-
11.5.4 Merck NSAIDs Drug Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Yunnan Baiyao
-
11.6.1 Yunnan Baiyao Company Details
-
11.6.2 Yunnan Baiyao NSAIDs Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Yunnan Baiyao NSAIDs Drug Main Business and Markets Served
-
11.6.4 Yunnan Baiyao NSAIDs Drug Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Eli Lilly
-
11.7.1 Eli Lilly Company Details
-
11.7.2 Eli Lilly NSAIDs Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Eli Lilly NSAIDs Drug Main Business and Markets Served
-
11.7.4 Eli Lilly NSAIDs Drug Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Depomed
-
11.8.1 Depomed Company Details
-
11.8.2 Depomed NSAIDs Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Depomed NSAIDs Drug Main Business and Markets Served
-
11.8.4 Depomed NSAIDs Drug Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Bayer
-
11.9.1 Bayer Company Details
-
11.9.2 Bayer NSAIDs Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Bayer NSAIDs Drug Main Business and Markets Served
-
11.9.4 Bayer NSAIDs Drug Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 AstraZeneca
-
11.10.1 AstraZeneca Company Details
-
11.10.2 AstraZeneca NSAIDs Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 AstraZeneca NSAIDs Drug Main Business and Markets Served
-
11.10.4 AstraZeneca NSAIDs Drug Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Grunenthal
-
11.11.1 Grunenthal Company Details
-
11.11.2 Grunenthal NSAIDs Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Grunenthal NSAIDs Drug Main Business and Markets Served
-
11.11.4 Grunenthal NSAIDs Drug Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 GSK
-
11.12.1 GSK Company Details
-
11.12.2 GSK NSAIDs Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 GSK NSAIDs Drug Main Business and Markets Served
-
11.12.4 GSK NSAIDs Drug Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Teva
-
11.13.1 Teva Company Details
-
11.13.2 Teva NSAIDs Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Teva NSAIDs Drug Main Business and Markets Served
-
11.13.4 Teva NSAIDs Drug Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Pfizer
-
11.14.1 Pfizer Company Details
-
11.14.2 Pfizer NSAIDs Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Pfizer NSAIDs Drug Main Business and Markets Served
-
11.14.4 Pfizer NSAIDs Drug Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Endo
-
11.15.1 Endo Company Details
-
11.15.2 Endo NSAIDs Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Endo NSAIDs Drug Main Business and Markets Served
-
11.15.4 Endo NSAIDs Drug Product Portfolio
-
11.15.5 Recent Research and Development Strategies
12 Global NSAIDs Drug Market Outlook by Types and Applications to 2028
-
12.1 Global NSAIDs Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Generic Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Branded Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global NSAIDs Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Drugstores Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise NSAIDs Drug Market Analysis and Outlook to 2028
-
13.1 Global NSAIDs Drug Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States NSAIDs Drug Consumption Forecast (2022-2028)
-
13.2.2 Canada NSAIDs Drug Consumption Forecast (2022-2028)
-
13.2.3 Mexico NSAIDs Drug Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany NSAIDs Drug Consumption Forecast (2022-2028)
-
13.3.2 UK NSAIDs Drug Consumption Forecast (2022-2028)
-
13.3.3 Spain NSAIDs Drug Consumption Forecast (2022-2028)
-
13.3.4 Belgium NSAIDs Drug Consumption Forecast (2022-2028)
-
13.3.5 France NSAIDs Drug Consumption Forecast (2022-2028)
-
13.3.6 Italy NSAIDs Drug Consumption Forecast (2022-2028)
-
13.3.7 Denmark NSAIDs Drug Consumption Forecast (2022-2028)
-
13.3.8 Finland NSAIDs Drug Consumption Forecast (2022-2028)
-
13.3.9 Norway NSAIDs Drug Consumption Forecast (2022-2028)
-
13.3.10 Sweden NSAIDs Drug Consumption Forecast (2022-2028)
-
13.3.11 Poland NSAIDs Drug Consumption Forecast (2022-2028)
-
13.3.12 Russia NSAIDs Drug Consumption Forecast (2022-2028)
-
13.3.13 Turkey NSAIDs Drug Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China NSAIDs Drug Consumption Forecast (2022-2028)
-
13.4.2 Japan NSAIDs Drug Consumption Forecast (2022-2028)
-
13.4.3 India NSAIDs Drug Consumption Forecast (2022-2028)
-
13.4.4 South Korea NSAIDs Drug Consumption Forecast (2022-2028)
-
13.4.5 Pakistan NSAIDs Drug Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh NSAIDs Drug Consumption Forecast (2022-2028)
-
13.4.7 Indonesia NSAIDs Drug Consumption Forecast (2022-2028)
-
13.4.8 Thailand NSAIDs Drug Consumption Forecast (2022-2028)
-
13.4.9 Singapore NSAIDs Drug Consumption Forecast (2022-2028)
-
13.4.10 Malaysia NSAIDs Drug Consumption Forecast (2022-2028)
-
13.4.11 Philippines NSAIDs Drug Consumption Forecast (2022-2028)
-
13.4.12 Vietnam NSAIDs Drug Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil NSAIDs Drug Consumption Forecast (2022-2028)
-
13.5.2 Colombia NSAIDs Drug Consumption Forecast (2022-2028)
-
13.5.3 Chile NSAIDs Drug Consumption Forecast (2022-2028)
-
13.5.4 Argentina NSAIDs Drug Consumption Forecast (2022-2028)
-
13.5.5 Venezuela NSAIDs Drug Consumption Forecast (2022-2028)
-
13.5.6 Peru NSAIDs Drug Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico NSAIDs Drug Consumption Forecast (2022-2028)
-
13.5.8 Ecuador NSAIDs Drug Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain NSAIDs Drug Consumption Forecast (2022-2028)
-
13.6.2 Kuwait NSAIDs Drug Consumption Forecast (2022-2028)
-
13.6.3 Oman NSAIDs Drug Consumption Forecast (2022-2028)
-
13.6.4 Qatar NSAIDs Drug Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia NSAIDs Drug Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates NSAIDs Drug Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria NSAIDs Drug Consumption Forecast (2022-2028)
-
13.7.2 South Africa NSAIDs Drug Consumption Forecast (2022-2028)
-
13.7.3 Egypt NSAIDs Drug Consumption Forecast (2022-2028)
-
13.7.4 Algeria NSAIDs Drug Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia NSAIDs Drug Consumption Forecast (2022-2028)
-
13.8.2 New Zealand NSAIDs Drug Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of NSAIDs Drug
-
Figure of NSAIDs Drug Picture
-
Table Global NSAIDs Drug Import by Region (Top 10 Countries) (2017-2028)
-
Table Global NSAIDs Drug Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Generic Consumption and Growth Rate (2017-2022)
-
Figure Global Branded Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Drugstores Consumption and Growth Rate (2017-2022)
-
Figure Global NSAIDs Drug Consumption by Country (2017-2022)
-
Table North America NSAIDs Drug Consumption by Country (2017-2022)
-
Figure United States NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Figure Canada NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Figure Mexico NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Table Europe NSAIDs Drug Consumption by Country (2017-2022)
-
Figure Germany NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Figure UK NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Figure Spain NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Figure Belgium NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Figure France NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Figure Italy NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Figure Denmark NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Figure Finland NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Figure Norway NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Figure Sweden NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Figure Poland NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Figure Russia NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Figure Turkey NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Table APAC NSAIDs Drug Consumption by Country (2017-2022)
-
Figure China NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Figure India NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Figure Pakistan NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Figure Indonesia NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Figure Thailand NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Figure Singapore NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Figure Malaysia NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Figure Philippines NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Figure Vietnam NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Table South America NSAIDs Drug Consumption by Country (2017-2022)
-
Figure Brazil NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Figure Colombia NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Figure Chile NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Figure Argentina NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Figure Venezuela NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Figure Peru NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Figure Ecuador NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Table GCC NSAIDs Drug Consumption by Country (2017-2022)
-
Figure Bahrain NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Figure Kuwait NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Figure Oman NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Figure Qatar NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Table Africa NSAIDs Drug Consumption by Country (2017-2022)
-
Figure Nigeria NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Figure South Africa NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Figure Egypt NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Figure Algeria NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Table Oceania NSAIDs Drug Consumption by Country (2017-2022)
-
Figure Australia NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Figure New Zealand NSAIDs Drug Consumption and Growth Rate (2017-2022)
-
Table Allergan Company Details
-
Table Allergan NSAIDs Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan NSAIDs Drug Main Business and Markets Served
-
Table Allergan NSAIDs Drug Product Portfolio
-
Table Purdue Company Details
-
Table Purdue NSAIDs Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Purdue NSAIDs Drug Main Business and Markets Served
-
Table Purdue NSAIDs Drug Product Portfolio
-
Table J&J Company Details
-
Table J&J NSAIDs Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table J&J NSAIDs Drug Main Business and Markets Served
-
Table J&J NSAIDs Drug Product Portfolio
-
Table Sanofi Company Details
-
Table Sanofi NSAIDs Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi NSAIDs Drug Main Business and Markets Served
-
Table Sanofi NSAIDs Drug Product Portfolio
-
Table Merck Company Details
-
Table Merck NSAIDs Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck NSAIDs Drug Main Business and Markets Served
-
Table Merck NSAIDs Drug Product Portfolio
-
Table Yunnan Baiyao Company Details
-
Table Yunnan Baiyao NSAIDs Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Yunnan Baiyao NSAIDs Drug Main Business and Markets Served
-
Table Yunnan Baiyao NSAIDs Drug Product Portfolio
-
Table Eli Lilly Company Details
-
Table Eli Lilly NSAIDs Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly NSAIDs Drug Main Business and Markets Served
-
Table Eli Lilly NSAIDs Drug Product Portfolio
-
Table Depomed Company Details
-
Table Depomed NSAIDs Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Depomed NSAIDs Drug Main Business and Markets Served
-
Table Depomed NSAIDs Drug Product Portfolio
-
Table Bayer Company Details
-
Table Bayer NSAIDs Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer NSAIDs Drug Main Business and Markets Served
-
Table Bayer NSAIDs Drug Product Portfolio
-
Table AstraZeneca Company Details
-
Table AstraZeneca NSAIDs Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca NSAIDs Drug Main Business and Markets Served
-
Table AstraZeneca NSAIDs Drug Product Portfolio
-
Table Grunenthal Company Details
-
Table Grunenthal NSAIDs Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Grunenthal NSAIDs Drug Main Business and Markets Served
-
Table Grunenthal NSAIDs Drug Product Portfolio
-
Table GSK Company Details
-
Table GSK NSAIDs Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK NSAIDs Drug Main Business and Markets Served
-
Table GSK NSAIDs Drug Product Portfolio
-
Table Teva Company Details
-
Table Teva NSAIDs Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva NSAIDs Drug Main Business and Markets Served
-
Table Teva NSAIDs Drug Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer NSAIDs Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer NSAIDs Drug Main Business and Markets Served
-
Table Pfizer NSAIDs Drug Product Portfolio
-
Table Endo Company Details
-
Table Endo NSAIDs Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Endo NSAIDs Drug Main Business and Markets Served
-
Table Endo NSAIDs Drug Product Portfolio
-
Figure Global Generic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Branded Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drugstores Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global NSAIDs Drug Consumption Forecast by Country (2022-2028)
-
Table North America NSAIDs Drug Consumption Forecast by Country (2022-2028)
-
Figure United States NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe NSAIDs Drug Consumption Forecast by Country (2022-2028)
-
Figure Germany NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure France NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC NSAIDs Drug Consumption Forecast by Country (2022-2028)
-
Figure China NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table South America NSAIDs Drug Consumption Forecast by Country (2022-2028)
-
Figure Brazil NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC NSAIDs Drug Consumption Forecast by Country (2022-2028)
-
Figure Bahrain NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa NSAIDs Drug Consumption Forecast by Country (2022-2028)
-
Figure Nigeria NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania NSAIDs Drug Consumption Forecast by Country (2022-2028)
-
Figure Australia NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand NSAIDs Drug Consumption Forecast and Growth Rate (2022-2028)
-
